Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 2 (MT-CO2) is a mitochondrially encoded protein forming an essential structural and functional component of complex IV (cytochrome c oxidase) in the mitochondrial electron transport chain. MT-CO2 is anchored in the mitochondrial inner membrane and plays a central role in electron transfer from cytochrome c to the catalytic core, contributing to the reduction of molecular oxygen to water. This process is essential for generating the proton gradient that drives ATP synthesis through oxidative phosphorylation. Dysfunction or mutations in MT-CO2 can result in severe mitochondrial diseases with variable presentations, including mitochondrial encephalomyopathy, myopathy, lactic acidosis, and organ-specific or multisystem dysfunction. Rare mutations act by disrupting electron transport, reducing ATP production, and promoting excessive reactive oxygen species formation, with disease severity depending on the mutation type and load.
Not targeted by specific drugs for therapy; mechanistically, inhibition leads to respiratory chain blockade, impaired ATP production, and increased reactive oxygen species
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 2 (MT-CO2).